| Authors: |
Rose AM; Epiconcept, Paris, France.; These authors contributed equally as first authors.; These authors contributed equally to the writing of the paper., Lucaccioni H; Epiconcept, Paris, France.; These authors contributed equally as first authors., Marsh K; Public Health Scotland, NHS Scotland, Glasgow, United Kingdom., Kirsebom F; UK Health Security Agency, London, England., Whitaker H; UK Health Security Agency, London, England., Emborg HD; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark., Bolt Botnen A; Department of Virology and Microbiological Preparedness, Statens Serum Institut, Copenhagen, Denmark., O'Doherty MG; Public Health Agency, Belfast, United Kingdom., Pozo F; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain., Hameed SS; Public Health Scotland, NHS Scotland, Glasgow, United Kingdom., Andrews N; UK Health Security Agency, London, England., Hamilton M; Public Health Scotland, NHS Scotland, Glasgow, United Kingdom., Trebbien R; Department of Virology and Microbiological Preparedness, Statens Serum Institut, Copenhagen, Denmark., Lauenborg Møller K; Data Integration and Analyses, Statens Serum Institut, Copenhagen, Denmark., Marques DF; Epiconcept, Paris, France., Murphy S; Public Health Agency, Belfast, United Kingdom., McQueenie R; Public Health Scotland, NHS Scotland, Glasgow, United Kingdom., Lopez-Bernal J; UK Health Security Agency, London, England., Cottrell S; Public Health Wales, Cardiff, Wales., Bucholc M; Public Health Agency, Belfast, United Kingdom., Kissling E; Epiconcept, Paris, France.; These authors contributed equally to the writing of the paper. |
